首页|无机载体在蛋白多肽类药物口服给药系统中的应用进展

无机载体在蛋白多肽类药物口服给药系统中的应用进展

Research Progress in the Application of Inorganic Carriers in the Oral Delivery System of Protein and Peptide Drugs

扫码查看
由于蛋白多肽类药物本身的理化性质,以及口服给药后复杂的pH和酶环境,黏液层屏障及肠上皮组织屏障等原因,致使其口服生物利用度低的难题长期未得到解决.无机纳米粒载体具有多孔刚性结构、载药量大、稳定性强等特点.对其表面进行修饰后能够提高穿黏液能力和跨膜转运能力,从而克服胃肠道生理屏障.本文介绍了蛋白多肽类药物口服给药系统的研究现状,生理屏障限制其口服吸收的机制及应对策略,以及无机材料作为载体在蛋白多肽类药物口服给药系统中的应用.
The development of oral delivery systems for protein and peptide drugs has long been the goal of the pharmaceutical field.However,extremely low bioavailability has been an unsolved problem in this research.This is related to the physical and chemical properties of the protein and peptides,as well as the three physiological barriers:the complex pH and enzyme environment after oral administration,the mucus barrier and the intestinal epithelial tissue barrier.With its porous rigid structure and high drug loading and strong stability,inorganic particle carrier has the ability to penetrate mucus and transport intestinal epithelia after surface modification,thus overcoming the three physiological barriers.This study introduces the current clinical application of protein and peptide drugs for oral administration,and the mechanism and coping strategies of physiological barrier that limit their oral absorption.Additionally,the application of inorganic materials as carriers in the oral delivery system of protein and peptide drugs are summarized.

inorganic carriersprotein and peptide drugoral delivery

宋小丹、丛可心、周秀婷、曹德英、宋玉品、高健、向柏

展开 >

河北医科大学药学院,石家庄 050017

石家庄学院,石家庄 050035

华北制药股份有限公司,石家庄 050015

无机载体 蛋白多肽类药物 口服给药

国家自然科学基金项目资助

81973251

2024

中国药学杂志
中国药学会

中国药学杂志

CSTPCD北大核心
影响因子:0.957
ISSN:1001-2494
年,卷(期):2024.59(11)
  • 74